Overview

A Placebo-Controlled Study of MK0634 in Patients With Overactive Bladder (0634-007)

Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
Overactive bladder is very prevalent in postmenopausal women. The current study is designed to investigate whether a new drug may offer safe and effective treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.